Incyte Corp
NASDAQ:INCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Incyte Corp
NASDAQ:INCY
|
US |
|
Booz Allen Hamilton Holding Corp
NYSE:BAH
|
US |
|
Orient Overseas (International) Ltd
F:ORI
|
HK |
|
Pollard Banknote Ltd
F:67L
|
CA |
|
Singapore Post Ltd
OTC:SPSTF
|
SG |
|
Encore Capital Group Inc
NASDAQ:ECPG
|
US |
|
C
|
China Resources Land Ltd
XMUN:CHZ
|
HK |
|
Chevron Corp
NYSE:CVX
|
US |
|
IPG Photonics Corp
NASDAQ:IPGP
|
US |
|
CleanBnB SpA
MIL:CBB
|
IT |
|
Haier Smart Home Co Ltd
F:HAI0
|
CN |
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
Intrinsic Value
Is INCY undervalued or overvalued?
See the intrinsic value estimate for Incyte Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Incyte Does
Incyte Corp is a biopharmaceutical company that discovers, develops, and sells prescription medicines, mainly for cancer and immune-related diseases. Its best-known products include treatments used by specialists in oncology and dermatology, where doctors prescribe the drugs to patients with conditions such as blood cancers, graft-versus-host disease, and inflammatory skin disorders.
- Headquarters
- United States of America US
- Employees
- 2 844
- IPO date
- Dec 6, 1993
Incyte has no economic moat
Incyte’s medicines face other treatments that doctors and patients can choose instead, and customers generally are not locked into using the company’s products. Patents can hold off copies for a time, but they do not protect the business indefinitely as other drugs compete for the same patients.
Read the full moat analysis
Revenue & Expenses Breakdown
Incyte Corp
Earnings Waterfall
Incyte Corp
The intrinsic value for Incyte Corp (INCY) under the Base Case is hidden USD.
Compared with the current market price of 120.29 USD, the stock appears hidden.